Original language | English |
---|---|
Pages (from-to) | 2355-2365 |
Number of pages | 11 |
Journal | Journal of Thoracic and Cardiovascular Surgery |
Volume | 156 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Thoracic and Cardiovascular Surgery, Vol. 156, No. 6, 12.2018, p. 2355-2365.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report
T2 - Identifying collaborative clinical research priorities in lung transplantation
AU - Mulligan, Michael S.
AU - Weill, David
AU - Davis, R. Duane
AU - Christie, Jason D.
AU - Farjah, Farhood
AU - Singer, Jonathan P.
AU - Hartwig, Matthew
AU - Sanchez, Pablo G.
AU - Kreisel, Daniel
AU - Ware, Lorraine B.
AU - Bermudez, Christian
AU - Hachem, Ramsey R.
AU - Weyant, Michael J.
AU - Gries, Cynthia
AU - Awori Hayanga, Jeremiah W.
AU - Griffith, Bartley P.
AU - Snyder, Laurie D.
AU - Odim, Jonah
AU - Craig, J. Matthew
AU - Aggarwal, Neil R.
AU - Reineck, Lora A.
N1 - Funding Information: This workshop was funded by the National Heart, Lung, and Blood Institute (NHLBI) and the American Association for Thoracic Surgery . Funding Information: M.S.M. is a consultant for Covidien/Medtronic and a Data and Safety Monitoring Board member for Perfusix. J.D.C. receives institutional research grant funding from GlaxoSmithKline and Bristol-Myers Squibb . M.H. is an investigator for Lung Bioengineering and Transmedics clinical trials, and a consultant for Mallinckrodt Pharmaceuticals. D.K. is a member of the scientific advisory board for Compass Therapeutics, receives research grant funding from Compass Therapeutics , and has a patent pending for “Compositions and Methods for Detecting CCR2 Receptors.” L.B.W. receives research contract funding from Boehringer Ingelheim and Global Blood Therapeutics , and is on the advisory board for CSL Behring and Bayer. R.R.H. is on the advisory board for Therakos, Theravance, and Vectura, and receives research funding from Therakos . M.J.W. is an educator and consultant for Medtronic. All other authors have nothing to disclose. Funding Information: M.S.M. is a consultant for Covidien/Medtronic and a Data and Safety Monitoring Board member for Perfusix. J.D.C. receives institutional research grant funding from GlaxoSmithKline and Bristol-Myers Squibb. M.H. is an investigator for Lung Bioengineering and Transmedics clinical trials, and a consultant for Mallinckrodt Pharmaceuticals. D.K. is a member of the scientific advisory board for Compass Therapeutics, receives research grant funding from Compass Therapeutics, and has a patent pending for “Compositions and Methods for Detecting CCR2 Receptors.” L.B.W. receives research contract funding from Boehringer Ingelheim and Global Blood Therapeutics, and is on the advisory board for CSL Behring and Bayer. R.R.H. is on the advisory board for Therakos, Theravance, and Vectura, and receives research funding from Therakos. M.J.W. is an educator and consultant for Medtronic. All other authors have nothing to disclose.
PY - 2018/12
Y1 - 2018/12
UR - http://www.scopus.com/inward/record.url?scp=85054158865&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2018.08.010
DO - 10.1016/j.jtcvs.2018.08.010
M3 - Article
C2 - 30244865
AN - SCOPUS:85054158865
SN - 0022-5223
VL - 156
SP - 2355
EP - 2365
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 6
ER -